The impact of pregnancy on rheumatoid arthritis outcome: The role of maternofetal HLA class II disparity

Joint Bone Spine

Volumn 77, Issue 1, 2010, Pages 36-40

  Zrour, Saoussen Hassen ^a   Boumiza, Radia ^a   Sakly, Nabil ^a   Mannai, Rim ^a   Korbaa, Wided ^a   Younes, Mohamed ^a   Bejia, Ismail ^a   Touzi, Mongi ^a   Bergaoui, Naceur ^a  

^a Monastir Teaching Hospital   (Tunisia)

Author keywords

Fetal; HLA antigens analysis; Maternal; Outcome; Pregnancy; Rheumatoid arthritis

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; INDOMETACIN; PARACETAMOL; PREDNISONE;

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; HLA TYPING; HUMAN; MOTHER FETUS RELATIONSHIP; PREGNANCY; PUERPERIUM; RELAPSE; REMISSION; RHEUMATOID ARTHRITIS;

ADULT; AMBULATORY CARE FACILITIES; ARTHRITIS, RHEUMATOID; FEMALE; FETAL BLOOD; FETUS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HISTOCOMPATIBILITY TESTING; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; INFANT, NEWBORN; MALE; MATERNAL-FETAL EXCHANGE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; PUERPERAL DISORDERS; RECURRENCE; REMISSION INDUCTION; SEVERITY OF ILLNESS INDEX;

EID: 73449131466     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2009.11.009     Document Type: Article

References (30)

1. Ostensen M., and Villiger P.M. Immunology of pregnancy-pregnancy as a remission inducing agent in rheumatoid arthritis. Transpl Immunol 9 (2002) 155-160
2. Russell A.S., Johnston C., Chew C., et al. Evidence for reduced Th1 function in normal pregnancy: a hypothesis for the remission of rheumatoid arthritis. J Rheumatol 24 (1997) 1045-1050
3. Berthelot J.-M. Modifications de la réponse immune durant la grossesse : implications dans la polyarthrite rhumatoïde et le lupus systémique. Rev Rhum 72 (2005) 686-694
4. Crocker I.P., Baker P.N., and Fletcher J. Neutrophil function in pregnancy and rheumatoid arthritis. Ann Rheum Dis 59 (2000) 555-564
5. Gilbert C. Neurotransmitter status and remission of rheumatoid arthritis in pregnancy. J Rheumatol 21 (1994) 1056-1060
6. Red Horse K., Drake P.M., and Fisher S.J. Human pregnancy: the role of chemokine networks at the fetal-maternal interface. Rep Med Rev 11 (2003) 87-103
7. Goupille P. Grossesse et polyarthrite rhumatoïde. Rev Rhum 64 (1997) 174-182
8. Hazes J.M. Fetomaternal HLA differences and the onset and course of rheumatoid arthritis. Rev Rhum Engl Ed 65 (1998) 611-613
9. Nelson J.L., Hughes K.A., Smith A.G., et al. Maternal-fetal disparity in HLA class II alloantigens and the pregnancy-induced amelioration of rheumatoid arthritis. New Engl J Med 329 (1993) 466-471
10. Van der Horst-Bruinsma I.E., de Vries R.R.P., Buck P.D.M., et al. Influence of HLA-class II incompatibility between mother and fetus on the development and course of rheumatoid arthritis of the mother. Ann Rheum Dis 57 (1998) 286-290
11. Brennan P., Barrett J., Fiddler M., et al. Maternal-fetal HLA incompatibility and the course of inflammatory arthritis during pregnancy. J Rheumatol 27 (2000) 2843-2848
12. Gregersen P.K. Pregnant with controversy [Editorial]. J Rheumatol 27 (2000) 12 [Editorial]
13. Scott DL, van Riel PL, van der Heijde D, et al. On behalf of the EULAR standing committee for international clinical studies including therapeutic trials. Assessing disease activity in rheumatoid arthritis. The EULAR handbook of standard methods.
14. Béjia I., Laatar A., Ben Salem K., et al. Validation de la version tunisienne du score HAQ chez les patients atteints de polyarthrite rhumatoïde. Tunis Med 84 (2006) 155-160
15. Fransen J., and van Riel P.L. The disease activity score and the EULAR response criteria. Clin Exp Rheumatol 23 5 Suppl. 39 (2005) S93-S99
16. Steinbrocker O., Traeger C.H., and Batterman R.C. Therapeutic criteria in rheumatoid arthritis. JAMA 140 (1949) 659-662
17. Pinals R.S., Masi A.T., and Larsen R.A. Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum 24 (1981) 1308-1315
18. Barrett J., Brennan P., Fiddler M., et al. Does rheumatoid arthritis remit during pregnancy and relapse postpartum?. Arthritis Rheum 42 (1999) 1219-1227
19. Ostensen M., Fuhrer L., Mathieu R., et al. A prospective study of pregnant patients with rheumatoid arthritis and ankylosisng spondylitis using validated clinical instruments. Ann Rheum Dis 63 (2004) 1212-1217
20. Musiej-Nowakowska E., and Ploski R. Pregnancy and early onset pauciarticular juvenile chronic arthritis. Ann Rheum Dis 58 (1999) 475-480
21. Weidler C., Härle P., Schedel J., et al. Patients with rheumatoid arthritis and systemic lupus erythematosus have increased renal excretion of mitogenic estrogens in relation to endogenous antiestrogens. J Rheumatol 31 (2004) 489-494
22. Cutolo M. Estrogen metabolites: increasing evidence for their role in rheumatoid arthritis and systemic lupus erythematosus. J Rheumatol 31 (2004) 419-421
23. Whyte A., and Williams R.O. Bromocriptine suppresses postpartum exacerbation of collagen-induced arthritis. Arthritis Rheum 31 (1988) 927-928
24. Jorgensen C., Picot M.C., Bologna C., et al. Oral contraception, parity, breast-feeding, and severity of rheumatoid arthritis. Ann Rheum Dis 55 (1996) 94-98
25. Valtysdottir S.T., Wide L., and Hallgren R. Mental Wellbeing and quality of sexual life in women with primary Sjogren's syndrome are related to circulating dehydroepiandrosterone sulphate. Ann Rheum Dis 62 (2003) 875-879
26. Tandon V.R., Sharma S., Mahajan A., et al. Pregnancy and rheumatoid arthritis. Indian J Med Sci 60 (2006) 334-344
27. Skomsvoll J.F., Baste V., Irgens L.M., et al. The recurrence risk of adverse outcome in the second pregnancy in women with rheumatic disease. Obstet Gynecol 100 (2002) 1196-1202
28. Drossaers-Baker K.W., Zwinderman A.H., Van Zeben D., et al. Pregnancy and oral contraceptive use do not significantly influence outcome in long-term rheumatoid arthritis. Ann Rheum Dis 61 (2002) 405-408
29. Silman A.J. Contraceptives, pregnancy and RA. Ann Rheum Dis 61 (2002) 383
30. van Dunné F.M., Lard L.R., Rook D., et al. Miscarriage but not fecundity is associated with progression of joint destruction in rheumatoid arthritis. Ann Rheum Dis 63 (2004) 956-960